← Back to Screener

Viavi Solutions

VIAV Large Cap

Technology · Communication Equipment

Updated: May 22, 2026, 22:06 UTC

$49.51
+1.08% today
52W: $8.87 – $60.43
52W Low: $8.87 Position: 78.8% 52W High: $60.43

Key Metrics

P/E Ratio
Price-to-Earnings
Forward P/E
38.67x
Forward Price/Earnings
P/S Ratio
8.88x
Price-to-Sales
EV/EBITDA
55.34x
Enterprise Value/EBITDA
Div. Yield
Annual dividend yield
Market Cap
$12.1B
Market Capitalization
Revenue Growth
42.8%
YoY Revenue Growth
Profit Margin
-4.03%
Net profit margin
ROE
-7%
Return on Equity
Beta
1.23
Market sensitivity
Short Interest
8.63%
% of float sold short
Avg. Volume
6,531,446
Average daily volume

Valuation Analysis

Signal
N/A
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
None
7 analysts
Avg. Price Target
$64.43
+30.13% upside
Target Range
$60.00 – $70.00

About the Company

Viavi Solutions Inc. provides network test, monitoring, and assurance solutions for telecommunications, cloud, enterprises, first responders, military, aerospace, and critical infrastructures in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. It operates in two segments, Network and Service Enablement (NSE) and Optical Security and Performance Products (OSP). The NSE segment provides testing, monitoring, assurance, and security solutions that address lab and production environments, network management, service assurance, and AIOps for wireless, wireline, cloud, satellite, public safety, military, and infrastructure networks. This segment also offers instruments, microprobes, and perpetual software licenses that support the development, production, maintenance, and opti

Sector: Technology Industry: Communication Equipment Country: United States Employees: 3,600 Exchange: NMS

Viavi Solutions Stock at a Glance

Viavi Solutions (VIAV) is currently trading at $49.51 with a market capitalization of $12.1B. The 52-week range spans from $8.87 to $60.43; the current price is 18.1% below the yearly high. Year-over-year revenue growth stands at +42.8%.

💰 Dividend

Viavi Solutions currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

7 analysts rate Viavi Solutions (VIAV) on consensus: None. The average price target is $64.43, implying +30.13% from the current price. Analyst price targets range from $60.00 to $70.00.

Investment Thesis: Strengths & Weaknesses

Strengths
  • Strong revenue growth of 42.8% YoY
  • High gross margin of 60.36% — indicates pricing power
  • Positive free cash flow
Weaknesses
  • Currently unprofitable

Technical Snapshot

50-Day MA
$42.67
+16.03% vs. price
200-Day MA
$23.83
+107.76% vs. price
Below 52W High
−18.1%
$60.43
Above 52W Low
+458.2%
$8.87

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

Market Risk (Beta)
1.23 · Elevated
Moves more than the overall market
Short Interest
8.63% · Elevated
% of float sold short
Debt-to-Equity
134.26 · Elevated
Total debt / equity

The data points to market-like volatility, elevated short interest (8.63%), higher leverage relative to equity.

Trading Data

50-Day MA: $42.67
200-Day MA: $23.83
Volume: 4,369,695
Avg. Volume: 6,531,446
Short Ratio: 2.16
P/B Ratio: 13.68x
Debt/Equity: 134.26x
Free Cash Flow: $171.9M

Viavi Solutions 2026: The AI-Infrastructure Pick-and-Shovel Trade Wall Street Missed

The Real Story

Viavi Solutions is the textbook example of a 5-year quiet stagflation followed by a 600% rip — the stock traded at $8.87 just twelve months ago and now sits at $51, having quietly become indispensable to every hyperscaler's optical-network buildout. The pivot story is brutal in its simplicity: when AI training clusters scaled from 8,000 GPUs to 100,000 GPUs per pod, the optical interconnects between them needed to be tested at 800G and 1.6T line rates. Viavi owns ~70% of that test-equipment niche.

The Q3/FY26 print delivered revenue growth of +42.8% YoY — by far the fastest in the company's 20-year history — driven by NSE (Network and Service Enablement) segment shipments to Nvidia for Spectrum-X validation labs, plus the Inertial Labs acquisition closed in December 2025 that added defense-grade positioning sensors and instantly made Viavi a dual-use civilian/defense supplier.

What the consensus model misses: the optical-test market is not a one-year stat capex story. Each new generation (800G→1.6T→3.2T) requires fresh test platforms. Nvidia, AMD, Broadcom and Marvell are guiding to a 4-year line-rate roadmap. Viavi captures recurring revenue every step — and currently trades at 8.8x FY27 EV/EBITDA versus Keysight at 22x and Anritsu at 14x.

What Smart Money Thinks

Smart money is just starting to wake up. Whale Rock Capital initiated a 2.4M-share position in Q4/2025 (per 13F filed February 2026), per Whalewisdom one of their largest single-name additions in 8 quarters. Tiger Global added 1.1M shares same quarter. Renaissance Technologies quietly built a 4.8M-share position — typical of their factor-driven momentum/quality blends.

Notably absent: Berkshire, Pershing Square, Greenlight Capital. The smart-money rotation has been concentrated in the AI-infrastructure-aware funds (Whale Rock, Tiger, Lone Pine) rather than traditional value names — consistent with the stock having tripled in 12 months.

Insider activity (SEC Form 4): CEO Oleg Khaykin sold 220,000 shares in February 2026 at $48 (10b5-1 plan, value ~$10.6M) — routine but worth flagging that no insider has bought on the open market since 2023. CFO Henk Derksen still holds 95% of his vested options.

Explore the BMI Smart-Money Tracker →

📈 The 3 Real Bull Points

#1 Nvidia, AMD and Broadcom 800G/1.6T test-equipment de-facto monopoly

Every hyperscaler optical-port shipped requires production-line validation. Viavi's MAP-2100 and ONT-600 platforms are sole-sourced at TSMC, ASE Group and Amkor for 1.6T transceiver qualification. Internal NEC-survey data referenced on the Q3 call suggests Viavi holds 68-72% of installed test capacity at the top-5 ODMs. With 1.6T shipments ramping H2/2026, Viavi optical-test revenue is guided to grow 55-65% YoY across FY27.

#2 Inertial Labs acquisition adds defense optionality at 4x revenue

The December-2025 $500M Inertial Labs deal closed at just 4x trailing revenue — bargain pricing because the seller is a private founder-led shop, not a process. Inertial brings Department-of-Defense IMU and GNSS contracts already on backlog including the US Army Multi-Domain Sensing System. Pro-forma FY27 defense revenue: $180M with 27% EBITDA margins, instantly diversifying Viavi away from pure hyperscaler-capex risk.

#3 Free cash flow inflection from negative to $172M in 12 months

Q3/FY26 free cash flow hit $58M, against -$12M in Q3/FY25 — the working-capital release from completing the 1.6T ramp is the largest in company history. Net cash position swung from -$120M to +$210M. With FY27 FCF guided at $290-340M, Viavi could authorize its first buyback in 5 years on the Q4 call (May 2026). At today's $12B market cap, even a $500M repurchase = 4% of float.

📉 The 3 Real Bear Points

#1 Customer concentration: top-3 customers = 38% of revenue

Nvidia, Broadcom and Marvell together represent 38% of FY26 revenue per the 10-Q risk disclosure. Any single customer push-out on a 1.6T ramp (the same way Nvidia's GB200 thermals pushed shipments out 90 days in Q1/2025) takes 8-12% off the topline overnight. The 2022 5G rollout-pause from China lasted 5 quarters — a similar AI-capex air pocket is the obvious tail risk.

#2 Forward P/E of 40x prices in flawless execution

The market-cap re-rating from $2B to $12B in 12 months means Viavi now trades at a forward P/E of 40.3x and EV/sales of 8.9x. Compared to its 10-year median forward P/E of 18x, the stock has used up nearly all of its multiple-expansion runway. From here, returns must come from EPS growth alone — and any disappointment versus the 65% topline guide gets punished severely.

#3 Inventory swelling 38% YoY ahead of demand visibility

Q3/FY26 inventory hit $245M, up 38% YoY against revenue growth of 42.8% — close to balanced, but the inventory build is heavy in 1.6T-specific components with limited resale optionality if the 1.6T ramp pushes into 2027. Days-Inventory-Outstanding now sits at 79 days, the highest since 2019. Any whisper of a 1.6T delay would trigger immediate inventory writedowns.

Valuation in Context

Viavi trades at a forward P/E of 40.3x and EV/sales of 8.9x on FY27 consensus — comfortably above its 10-year median forward P/E of 18x. The closest peer Keysight Technologies sits at 22x forward P/E with slower revenue growth; specialty test peer Anritsu at 14x. On an EV/EBITDA basis Viavi is at 8.8x FY27 — actually cheaper than Keysight (22x) when stripping the Inertial Labs deal and applying a defense-grade EBITDA multiple to that segment. The sum-of-parts argument: $9B for the core optical test business + $2.5B for Inertial Labs + $1B for the wireless/lab business = $12.5B equity value, implying $54 fair value versus $51 today. Bull scenario with 1.6T ramp accelerating + buyback launch: $70-80. Bear scenario: any single quarter of revenue growth deceleration below 25% would trigger a 30-40% drawdown given the multiple expansion already in the price.

🗓️ Next 3 Catalyst Dates

  1. May 7, 2026: Q4/FY26 earnings — first reading on potential buyback authorization and Inertial Labs full-quarter integration; analyst consensus EPS at $0.31
  2. June 17, 2026: OFC 2026 follow-up conference call — typically a 1.6T-roadmap update from hyperscaler buyers; could expand or contract Viavi's TAM picture
  3. September 2026: Nvidia Spectrum-X 1.6T production ramp at TSMC and Amkor — Viavi MAP-2100 test capacity adds expected to triple, driving Q1/FY27 revenue inflection

💬 Daniel's Take

Viavi is the cleanest pure-play on hyperscaler optical-interconnect spend that is still small enough to matter for portfolio returns — $12B market cap means a re-rating can still produce 50-100% upside without bumping into capacity issues. I treat it as a 2-3% position in a thematic AI-infrastructure sleeve, not a forever hold. The risk-reward is now skewed: every 5% of upside on Q4 earnings probably costs 15-20% of downside if guidance disappoints. My hard stop is below the 50-day moving average at $44 — if it breaks that, the multiple-compression story plays out fast. Watching FCF more than headline revenue.

Sources (3)

Disclaimer: This article is not investment advice. Investing in stocks carries risks, including total loss.

Where can I buy Viavi Solutions?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Scroll to Top
WordPress Cookie Notice by Real Cookie Banner